Skip to main content
  • Article
  • Published:

Effect of epitope-CpG-DNA-liposome complex without carriers on vaccination of respiratory syncytial virus infection

Abstract

Respiratory syncytial virus (RSV) is a common virus related to disease in the lung epithelium of young children and infants. However, RSV vaccine has not yet been developed. Thus it is difficult to develop a whole-RSV vaccine due to induction of Th2-type hyper-immune responses. To overcome this limitation, we used CpG-DNA encapsulated within liposome complex (Lipoplex(O)) as an adjuvant for the induction of a Th1-dominated humoral response in animal experiments. However, vaccination with a complex of UV-irradiated RSV and Lipoplex(O) had no effect against RSV infection. To improve the efficacy of the RSV vaccine, we performed peptide-based epitope screening and evaluated the efficacy of the vaccine using a complex of epitope and Lipoplex(O). Two efficient B-cell epitopes were identified in nine candidate epitopes from the RSV-F protein. The vaccination with a complex of RSV-F protein epitope (F7 and F9) and Lipoplex(O), induced a prophylactic effect on the RSVinfection based on lung histopathology and mucus clearance from the lungs. Thus, further studies on the effect of the peptide vaccine against infection by multiple RSV strains, may allow fine-tuning of a potential vaccine, and improvement of the vaccine program against RSV.

References

  • Ballas ZK, Krieg AM, Warren T, Rasmussen W, Davis HL, Waldschmidt M, and Weiner GJ. (2001) Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs. J Immunol 167, 4878–86.

    Article  CAS  Google Scholar 

  • Blount RE Jr, Morris JA, and Savage RE. (1956) Recovery of cytopathogenic agent from chimpanzees with coryza. Proc Soc Exp Biol Med 92, 544–9.

    Article  Google Scholar 

  • Breary SP and Smyth RL. (2007) Pathogenesis of RSV in Children. P.A. Cane (Ed.), Respiratory Syncytial Virus, Perspectives in Medical Virology, vol. 14 Elsevier Publishers, Amsterdam, 141–62.

    Article  Google Scholar 

  • Broide D, Schwarze J, Tighe H, Gifford T, Nguyen MD, Malek S, Van Uden J, Martin-Orozco E, Gelfand EW, and Raz E. (1998) Immunostimulatory DNA sequences inhibit IL-5, eosinophilic inflammation, and airway hyperresponsiveness in mice. J Immunol 161, 7054–62.

    CAS  Google Scholar 

  • Connors M, Giese NA, Kulkarni AB, Firestone CY, Morse HC, and Murphy BR. (1994) Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSVimmunized BALB/c mice is abrogated by depletion of interleukin-4 (IL- 4) and IL-10. J Virol 68, 5321–5.

    CAS  Google Scholar 

  • Connors M, Kulkarni AB, Firestone CY, Holmes KL, Morse HC, Sotnikov AV, and Murphy BR. (1992) Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J Virol 66, 7444–51.

    CAS  Google Scholar 

  • Corvaïa N, Tournier P, Nguyen TN, Haeuw JF, Power UF, Binz H, and Andréoni C. (1997) Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2NA, in aluminum hydroxide. J Infect Dis 176, 560–9.

    Article  Google Scholar 

  • Culley FJ, Pollott J, and Openshaw PJ. (2002) Age at first viral infection determines the pattern of T cell-mediated disease during reinfection in adulthood. J Exp Med 196, 1381–6.

    Article  CAS  Google Scholar 

  • Delgado MF, Coviello S, Monsalvo AC, Melendi GA, Hernandez JZ, Batalle JP, Diaz L, Trento A, Chang HY, Mitzner W, Ravetch J, Melero JA, Irusta PM, and Polack FP. (2009) Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat Med 15, 34–41.

    Article  CAS  Google Scholar 

  • Deng GM, Nilsson IM, Verdrengh M, Collins LV, and Tarkowski A. (1999) Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 5, 702–5.

    Article  CAS  Google Scholar 

  • Deshpande SA and Northern V. (2003) The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defined geographical area. Arch Dis Child 88, 1065–9.

    Article  CAS  Google Scholar 

  • Eisenberg D, Weiss RM, and Terwilliger TC. (1984) The hydrophobic moment detects periodicity in protein hydrophobicity. Proc Natl Acad Sci USA 81, 140–4.

    Article  CAS  Google Scholar 

  • Emini EA, Hughes JV, Perlow DS, and Boger J. (1985) Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55, 836–9.

    CAS  Google Scholar 

  • Harris J and Werling D. (2003) Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response. Cell Microbiol 5, 671–80.

    Article  CAS  Google Scholar 

  • Haynes LM, Jones LP, Barskey A, Anderson LJ, and Tripp RA. (2003) Enhanced disease and pulmonary eosinophilia associated with formalininactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J Virol 77, 9831–44.

    Article  CAS  Google Scholar 

  • Heikenwalder M, Polymenidou M, Junt T, Sigurdson C, Wagner H, Akira S, Zinkernagel R, and Aguzzi A. (2004) Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 10, 187–92.

    Article  CAS  Google Scholar 

  • Jameson BA and Wolf H. (1988) The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 4, 181–6.

    CAS  Google Scholar 

  • Katz BZ, Lo J, and Sorrentino M. (2003) Costs of Respiratory Syncytial Virus Infection at a Tertiary-Care Children’s Hospital. Pharmacol Ther 28, 343–5.

    Google Scholar 

  • Kim D, Kwon HJ, and Lee Y (2011b) Activation of Toll-like receptor 9 and production of epitope specific antibody by liposome-encapsulated CpGDNA. BMB Rep 44, 607–12.

    Article  CAS  Google Scholar 

  • Kim D, Kwon S, Ahn CS, Lee Y, Choi SY, Park J, Kwon HY, and Kwon HJ (2011c) Adjuvant effect of liposome-encapsulated natural phosphodiester CpG-DNA. BMB Rep 44, 758–63.

    Article  CAS  Google Scholar 

  • Kim D, Kwon S, Rhee JW, Kim KD, Kim YE, Park CS, Choi MJ, Suh JG, Kim DS, Lee Y, and Kwon HJ (2011a) Production of antibodies with peptide-CpG-DNA-liposome complex without carriers. BMC Immunol 12:29.

    Article  CAS  Google Scholar 

  • Kim D, Rhee JW, Kwon S, Sohn WJ, Lee Y, Kim DW, Kim DS, and Kwon HJ. (2009) Immunostimulation and anti-DNA antibody production by backbone modified CpG-DNA. Biochem Biophys Res Commun 379, 362–7

    Article  CAS  Google Scholar 

  • Kim HW, Canchola JG, Brandt CD, Pyles G, Chanock RM, Jensen K, and Parrott RH. (1969) Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 89, 422–34.

    CAS  Google Scholar 

  • Kim S, Jang JE, Yu JR, and Chang J. (2010) Single mucosal immunization of recombinant adenovirus-based vaccine expressing F1 protein fragment induces protective mucosal immunity against respiratory syncytial virus infection. Vaccine 28, 3801–8.

    Article  CAS  Google Scholar 

  • Klinman DM, Currie D, Gursel I, and Verthelyi D. (2004) Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199, 201–16.

    Article  CAS  Google Scholar 

  • Kong X, San Juan H, Kumar M, Behera AK, Mohapatra A, Hellermann GR, Mane S, Lockey RF, and Mohapatra SS. (2003) Respiratory syncytial virus infection activates STAT signaling in human epithelial cells. Biochem Biophys Res Commun 306, 616–22.

    Article  CAS  Google Scholar 

  • Kwon S, Kim D, Park BK, Cho S, Kim KD, Kim YE, Park CS, Ahn HJ, Seo JN, Choi KC, Kim DS, Lee Y, and Kwon HJ. (2012) Prevention and therapy of hepatocellular carcinoma by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex without carriers. PLoS One 7, e33121.

    Article  Google Scholar 

  • Kwon S, Kim D, Park BK, Wu G, Park MC, Ha YW, Kwon HJ, and Lee Y. (2013) Induction of immunological memory response by vaccination with TM4SF5 epitope-CpG-DNA-liposome complex in a mouse hepatocellular carcinoma model. Oncol Rep 29, 735–40.

    CAS  Google Scholar 

  • Kyte J and Doolittle RF. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157, 105–32.

    Article  CAS  Google Scholar 

  • Lee KW, Jung J, Lee Y, Kim TY, Choi SY, Park J, Kim DS, and Kwon HJ. (2006) Immunostimulatory oligodeoxynucleotide isolated from genome wide screening of Mycobacterium bovis chromosomal DNA. Mol Immunol 43, 2107–18.

    Article  CAS  Google Scholar 

  • Melero JA. (2007) In Respiratory syncytial virus, Cane PA (ed.), Perspectives in Medical Virology 14, 1–42, Elsevier Publishers, Netherlands.

    Article  CAS  Google Scholar 

  • Nallet S, Amacker M, Westerfeld N, Baldi L, König I, Hacker DL, Zaborosch C, Zurbriggen R, and Wurm FM. (2009) Respiratory syncytial virus subunit vaccine based on a recombinant fusion protein expressed transiently in mammalian cells. Vaccine 27, 6415–9

    Article  CAS  Google Scholar 

  • Resch B, Gusenleitner W, and Müller W. (2002) The impact of respiratory syncytial virus infection: a prospective study in hospitalized infants younger than 2 years. Infection 30, 193–7.

    Article  CAS  Google Scholar 

  • Rhee JW, Kim D, Park BK, Kwon S, Cho S, Lee I, Park MS, Seo JN, Kim YS, Choi HS, Lee Y, and Kwon HJ. (2012) Immunization with a hemagglutinin-derived synthetic peptide formulated with a CpG-DNAliposome complex induced protection against lethal influenza virus infection in mice. PLoS One 7, e48750.

    Article  Google Scholar 

  • Simoes EA. (2003) Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. J Pediatr 143(5 Suppl), S118–26.

    Article  Google Scholar 

  • Sparwasser T, Hultner L, Koch ES, Luz A, Lipford GB, and Wagner H. (1999) Immunostimulatory CpG-oligodeoxynucleotides cause extramedullary murine hemopoiesis. J Immunol 162, 2368–74.

    CAS  Google Scholar 

  • Walsh EE and Falsey AR. (2012) Respiratory syncytial virus infection in adult populations. Infect Disord Drug Targets 12, 98–102.

    Article  CAS  Google Scholar 

  • Wertz GW, Stott EJ, Young KK, Anderson K, and Ball LA. (1987) Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice. J Virol 61, 293–301.

    CAS  Google Scholar 

  • Xie C, He JS, Zhang M, Xue SL, Wu Q, Ding XD, Song W, Yuan Y, Li DL, Zheng XX, Lu YY, and Shang Z. (2007) Oral respiratory syncytial virus (RSV) DNA vaccine expressing RSV F protein delivered by attenuated Salmonella typhimurium. Hum Gene Ther 18, 746–52.

    Article  CAS  Google Scholar 

  • Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, Wagner H, and Heeg K. (1998) CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J Immunol 160, 3627–30.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hyung-Joo Kwon.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Park, B.K., Kim, D., Wu, G. et al. Effect of epitope-CpG-DNA-liposome complex without carriers on vaccination of respiratory syncytial virus infection. J Korean Soc Appl Biol Chem 57, 667–676 (2014). https://doi.org/10.1007/s13765-014-4215-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13765-014-4215-9

Keywords